Follow
Prof. Harvinder Popli
Prof. Harvinder Popli
Delhi Pharmaceutical Sciences and Research University
Verified email at dpsru.edu.in - Homepage
Title
Cited by
Cited by
Year
Diabetes mellitus treatment using herbal drugs
S Verma, M Gupta, H Popli, G Aggarwal
International Journal of Phytomedicine 10 (1), 1-10, 2018
1162018
Poloxamer
JH Collett, H Popli, AH Kibbe
Handbook of pharmaceutical excipients, 385-388, 2000
602000
Novel drug delivery strategies for the treatment of onychomycosis
RK Dhamoon, H Popli, M Gupta
Pharmaceutical nanotechnology 7 (1), 24-38, 2019
502019
Quercetin loaded silver nanoparticles in hydrogel matrices for diabetic wound healing
R Badhwar, B Mangla, YR Neupane, K Khanna, H Popli
Nanotechnology 32 (50), 505102, 2021
362021
Trends in oral sustained release formulation-I
SNS H.Popli
Eastern Pharmacist, 1989
341989
A comprehensive review on Citrus aurantifolia essential oil: its phytochemistry and pharmacological aspects
S Jain, P Arora, H Popli
Brazilian Journal of Natural Sciences 3 (2), 354-354, 2020
332020
Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy
K Khanna, N Sharma, S Rawat, N Khan, R Karwasra, N Hasan, A Kumar, ...
Chemistry and Physics of Lipids 236, 105060, 2021
292021
Regulations of nutraceuticals in India & US
B Verma, H Popli
Pharma Innovation 7 (7), 811-816, 2018
192018
Pathophysiology of obesity-induced health complications
PS Tappia, B Ramjiawan, NS Dhalla
Springer, 2020
162020
ROLE OF ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKETING:A COMPREHENSIVE REVIEW
HP Vaishali Khanna*, Rakhi Ahuja
Journal of Advanced Scientific Research 11 (3), 2020
142020
niosomal delivery of tenoxicam
MS H.Popli
Indian Journal of Pharmaceutical Sciences, 1996
141996
Design-of-experiments (doe)-assisted fabrication of quercetin-loaded nanoemulgel and its evaluation against human skin cancer cell lines
A Chitkara, B Mangla, P Kumar, S Javed, W Ahsan, H Popli
Pharmaceutics 14 (11), 2517, 2022
132022
soild dispersion as drug delivery system for sulphamethoxazole and nitrofurantoin
BDM H.Popli
Indian Journal of Hospital Pharmacy 31, 1994
131994
Evaluation of sustained release formulations
H Popli, SN Sharma
The eastern pharmacist 33 (385), 75, 1990
131990
Cosmetics: Regulatory and market scenario for us and India
M Ruhela, L Nagar, A Gupta, H Popli
The Pharma Innovation Journal 7 (6), 164-169, 2018
112018
Pharmaceuticals, cosmeceuticals and nutraceuticals: an overview of regulations
N Udupa, H Popli
Career Publications, 2010
112010
Particle size characterization-techniques, factors and quality-by-design approach
RK Dhamoon, H Popli, G Aggarwal, M Gupta
International Journal of Drug Delivery 10 (1), 01-11, 2018
102018
Nanotheranostics for diagnosis and treatment of breast cancer
P Patel, K Kumar, VK Jain, H Popli, AK Yadav, K Jain
Current Pharmaceutical Design 29 (10), 732-747, 2023
92023
Nanoemulsions as effective carriers for targeting brain tumors
T Suthar, VK Jain, H Popli, K Jain
Nanocarriers for Drug-Targeting Brain Tumors, 347-363, 2022
92022
Medical devices regulation in United States of America, European Union and India: A comparative study
R Sethi, H Popli, S Sethi
Pharm. Regul. Aff, 2017
92017
The system can't perform the operation now. Try again later.
Articles 1–20